Can IP Waivers Resolve Vaccine Inequity?

Morning Run · Morning Brief · 10 May 2021 · 13 mins listen

With glaring inequities in the supply and distribution of vaccines, the Biden administration has backed a plan to waive intellectual property rights for Covid-19 vaccines and treatments. We speak to Dr. Lindsay Newman, Director of Economics & Country Risk from IHS Markit on whether this could provide a solution to help end the pandemic.

Image Credit: Shutterstock.com

Produced by:

Shazana Mokhtar

Presented by:

Khoo Hsu Chuang,Philip See

Categories:

Business Analysis,Trends and Forecasts,Markets,Politics,law & legal matters,Health Policy,Diseases & Conditions,Mental Health,Healthy Living,Fitness,Science,Investments

Tags:

vaccine,intellectual property,waiver,pandemic

Related Content

Health & Living · 13 Nov 2024 · 47 mins

Public Health: Why Was Pneumonia The Top Cause Of Death in 2023?

Azrul Mohd Khalib, CEO, Galen Centre for Health & Social PolicyProfessor Dr Ahmad Izuanuddin Ismail, President, Malaysian Thoracic SocietyDr Mohd Arif Mohd Zim, Consultant Respiratory Physician